Skip to Content
Merck

HANG2MAG-12K

MILLIPLEX® Human Angiogenesis Panel 2, HANG2MAG-12K

Angiogenesis Bead-Based Multiplex Assays using the Luminex technology enables the simultaneous analysis of multiple angiogenic biomarkers in human serum, plasma and cell culture samples.

Sign In to View Organizational & Contract Pricing.

About This Item

UNSPSC Code:
12161503
NACRES:
NA.84
eCl@ss:
32161000

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

MILLIPLEX® Human Angiogenesis Panel 2, HANG2MAG-12K, Angiogenesis Bead-Based Multiplex Assays using the Luminex technology enables the simultaneous analysis of multiple angiogenic biomarkers in human serum, plasma and cell culture samples.

species reactivity

human

manufacturer/tradename

Milliplex®

assay range

accuracy: 88-97%
standard curve range: 137-100,000 pg/mL
(Thrombospondin-2)
standard curve range: 137-100,000 pg/mL
(sVEGFR2)
standard curve range: 137-100,000 pg/mL
(suPAR)
standard curve range: 14-10,000 pg/mL
(sAXL)
standard curve range: 14-10,000 pg/mL
(sHER3)
standard curve range: 14-10,000 pg/mL
(sVEGFR1)
standard curve range: 27-20,000 pg/mL
(sIL-6Rα)
standard curve range: 27-20,000 pg/mL
(sPECAM-1)
standard curve range: 27-20,000 pg/mL
(sTIE-2)
standard curve range: 274-200,000 pg/mL
(Angiostatin)
standard curve range: 274-200,000 pg/mL
(sE-Selectin)
standard curve range: 274-200,000 pg/mL
(sNeuropilin-1)
standard curve range: 41-30,000 pg/mL
(Osteopontin (OPN))
standard curve range: 41-30,000 pg/mL
(sEGFR)
standard curve range: 41-30,000 pg/mL
(sHER2)
standard curve range: 41-30,000 pg/mL
(sc-Kit/sSCFR)
standard curve range: 412-300,000 pg/mL
(sVEGFR3)
standard curve range: 69-50,000 pg/mL
(sHGFR)
standard curve range: 7-5,000 pg/mL
(PDGF-AB/BB)

technique(s)

multiplexing: suitable

Quality Level

200

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

Related Categories

Application

  • Analytes: Angiostatin, soluble AXL (sAXL) , soluble c-Kit/Stem Cell Growth Factor Receptor (sc-Kit/SCFR), soluble E-Selectin (sE-Selectin), soluble Epidermal Growth Factor Receptor (sEGFR/sErbB1/sHER1)†, soluble Human Epidermal Growth Factor Receptor 2 (sHer2/sHER2/sErbB2), soluble Human Epidermal Growth Factor Receptor 3 (sHer3/ sHER3 / sErbB3), soluble Hepatocyte Growth Factor Receptor (sHGFR/c-Met/sc-Met), soluble IL-6Rα (IL-6Rα (soluble)/sIL-6Rα), soluble Neuropilin-1 (sNRP-1), Osteopontin (OPN), Platelet Derived Growth Factor-AB/BB (PDGF-AB/BB), soluble Platelet Endothelial Cell Adhesion Molecule-1 (sPECAM-1/sCD31), Thrombospondin-2 (TSP-2), soluble Tie-2 (sTie-2), soluble Urokinase-type Plasminogen Activator Receptor (suPAR), soluble Vascular Endothelial Growth Factor Receptor 1 (soluble VEGFR1, sVEGFR1/ sFlt-1), soluble Vascular Endothelial Growth Factor Receptor 2 (soluble VEGFR2/sVEGFR2/ sKDR/sFlk-1), soluble Vascular Endothelial Growth Factor Receptor 3 (soluble VEGFR3/sVEGFR3/ sFlt-4).
  • †Antibody against active site results in preferential binding to unbound EGFR.
  • Recommended Sample Type: Human serum, plasma, cell culture supernatants and tissue/cell homogenates/lysates
  • Recommended Sample Dilution: 25 μL per well of 1:5 diluted plasma or serum; cell culture supernatant may be used undiluted or diluted with appropriate control medium
  • Assay Run Time: Overnight (16-18 hours) at 2-8°C
  • Research Category: Cancer

Features and Benefits

Design your multiplex kit by choosing available analytes within this panel.

General description

Angiogenesis, the development of new vascular networks, is a key process in normal growth and development as well as in wound healing, with homeostasis maintained by a delicate balance of angiogenic factors and inhibitors. Consequently, insufficient, or excessive blood vessel growth underlies many diseases, including cardiovascular disease, diabetic ulcers, macular degeneration, and cancer. Angiogenesis plays a significant role in tumor growth and metastasis.

MILLIPLEX® Human Angiogenesis Magnetic Bead Panel 2 is a 19-plex kit to be used for the simultaneous quantification of any or all of the following analytes in serum, plasma, cell culture samples, and tissue homogenates/lysates: Angiostatin, soluble E-Selectin, (sE-Selectin), Osteopontin (OPN), Platelet Derived Growth Factor-AB/BB (PDGF-AB/BB), soluble Platelet Endothelial Cell Adhesion Molecule-1 (sPECAM-1), Thrombospondin-2 (TSP-2), soluble AXL (sAXL), soluble c-Kit/Stem Cell Growth Factor Receptor (sc-Kit/SCFR), soluble Epidermal Growth Factor Receptor (sEGFR)†, soluble Human Epidermal Growth Factor Receptor 2 (sHer2), soluble Human Epidermal Growth Factor Receptor 3 (sHer3), soluble Hepatocyte Growth Factor Receptor/c-Met (sHGFR/c-Met), soluble IL-6Rα, soluble Neuropilin-1 (sNRP-1), soluble Tie-2 (sTie-2), soluble Urokinase-type Plasminogen Activator Receptor (suPAR), soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1), soluble Vascular Endothelial Growth Factor Receptor 2 (sVEGFR2), and soluble Vascular Endothelial Growth Factor Receptor 3 (sVEGFR3). This kit uses a 96-well format, contains a lyophilized standard cocktail, two internal assay quality controls and can measure up to 38 samples in duplicate.

†Antibody against active site results in preferential binding to unbound EGFR.

The Luminex® xMAP® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.

Panel Type: Circulating Cancer

Other Notes

Please contact Technical Service for linearity of dilution.
Sensitivity: See kit protocol for individual analytes sensitivities.

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

target_organs

Respiratory Tract

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Sayuri Padayachee et al.
Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria, 37(1), 29-34 (2022-08-11)
A dysregulation of angiogenic mediators has been implicated in HIV infection. Inconsistent data exists on highly active antiretroviral therapy (HAART) usage in pregnancy and its association with PE development. In view of the high prevalence of HIV infection and PE
Juan Pablo Hinestrosa et al.
Communications medicine, 2, 29-29 (2022-05-24)
Detecting cancer at early stages significantly increases patient survival rates. Because lethal solid tumors often produce few symptoms before progressing to advanced, metastatic disease, diagnosis frequently occurs when surgical resection is no longer curative. One promising approach to detect early-stage

Related Content

がん研究のためのマルチプレックスがんアッセイ | MILLIPLEX® アッセイ

MILLIPLEX® マルチプレックスがんアッセイでがんバイオマーカーを検出することにより、腫瘍形成プロセスの研究が加速し、がん研究の進展に役立ちます。

がん・転移におけるシグナル伝達経路のマルチプレックス測定 | MILLIPLEX® アッセイ

MILLPLEXマルチプレックスアッセイで複数の血中バイオマーカーを一度に測定することにより、がん研究を容易にする方法をご覧ください。JAK-STAT、mTOR、MAPK、SAPK、TGFβシグナル伝達経路などを解析するためのマルチプレックスパネルを検索してください。

化粧品とパーソナルケア製品の研究のためのイムノアッセイ

化粧品やパーソナルケア製品の研究において、イムノアッセイを使用して炎症や感作、老化、組織再生に関するバイオマーカーを評価し、化粧品の潜在的な有害作用を調べる方法について紹介します。

Quality Control Range Sheet- HAGP2-109 and HAGP2-209
See All

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service